Thomas Jefferson University

Kenneth Iczkowski

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Masud N, Aldahish A, Iczkowski KA, Kale A, Shah GV. [Retracted] Zinc finger protein-like 1 is a novel neuroendocrine biomarker for prostate cancer. Int J Oncol. 2025 Mar; 66(3). PMID: 39917995.
      Citations:    
    2. Sangoi AR, Shahabi A, Hirsch MS, Kao CS, Deebajah M, Barletta JA, Paner GP, Smith SC, Grignon DJ, Comp?rat E, Amin MB, Maclean F, Shah RB, Iczkowski KA, Delprado W, Cheng L, Pan CC, McKenney JK, Ro JY, Khani F, Montironi R, Robinson BD, Al-Ahmadie H, Epstein JI, Trpkov K, Tretiakova M, Shen SS, Alanee S, Weight CJ, Akgul M, Williamson SR. Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations. Am J Clin Pathol. 2024 Dec 25. PMID: 39720998.
      Citations:    
    3. Bernhardt M, Weinhold L, Bremmer F, Chan E, Cheng L, Collins K, Downes M, Greenland N, Hommerding O, Iczkowski KA, Jufe L, Kreft T, van Leenders G, Oxley J, Perry-Keene J, Reis H, Schmid M, Tsuzuki T, Wobker S, Wiliamson SR, Kweldam C, Kristiansen G. Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance. Histopathology. 2025 Mar; 86(4):627-639. PMID: 39610035.
      Citations:    
    4. Yan H, Mao AW, Li D, P?rez-Baena MJ, Jim?nez-Navas A, Wang D, Hong R, Cai W, P?rez-Losada J, Jen KY, Wang S, Peng S, Barcellos-Hoff MH, Mao JH, Fu Y, Iczkowski KA, Gulati S, Chang H. AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study. medRxiv. 2024 Nov 18. PMID: 39606414.
      Citations:    
    5. Shakroo YM, Seabury CA, Iczkowski KA, Nelson K, Qian J, Ramnani DM. Germline pathogenic variants in prostate cancer. Pathol Res Pract. 2024 Dec; 264:155718. PMID: 39541765.
      Citations:    
    6. Varma M, Amin MB, Berney DM, Comp?rat E, Epstein JI, Iczkowski KA, Kristiansen G, Paner GP, Shah RB, Shaw G, van der Kwast TH, van Leenders GJ, Zhou M, Williamson SR. Histological sampling protocols for transurethral resection of prostate specimens need reappraisal. Histopathology. 2024 Nov; 85(5):746-747. PMID: 39252552.
      Citations:    
    7. Iczkowski KA, Parikh M. Divergences in neuroendocrine prostate cancer frequency as recognized by anatomic pathologists, clinicians, and basic scientists. Asian J Androl. 2025 Jan 01; 27(1):1-3. PMID: 39162145.
      Citations:    
    8. Lobo A, Collins K, Kaushal S, Acosta AM, Akgul M, Adhya AK, Al-Ahmadie HA, Al-Obaidy KI, Amin A, Amin MB, Aron M, Balzer BL, Biswal R, Mohanty S, Browning L, Chakrabarti I, Cima L, Cimadamore A, Desai S, Dhillon J, Deshwal A, Diego GG, Diwaker P, Galea LA, Magi-Galluzzi C, Giannico GA, Gupta NS, Haider A, Hirsch MS, Iczkowski KA, Arora S, Jain E, Jain D, Jha S, Kandukuri S, Kao CS, Kryvenko ON, Kumar RM, Kumari N, Kunju LP, Kuthi L, Lobo J, Lopez JI, Luthringer DJ, Maclean F, Manini C, Mannan R, Martos MG, Mehra R, Menon S, Mishra P, Moch H, Montironi R, Baisakh MR, Netto GJ, Nigam LK, Osunkoya AO, Pagliuca F, Paner GP, Panizo A, Parwani AV, Picken MM, Prendeville S, Przybycin CG, Purkait S, Queipo FJ, Rao BV, Rao P, Reuter VE, Sancheti S, Sangoi AR, Sardana R, Satturwar S, Shah RB, Sharma S, Dixit M, Verma M, Sirohi D, Smith SC, Soni S, Sundaram S, Swain M, Tretiakova M, Trpkov K, Mu?izUnamunzaga G, Zhou M, Williamson SR, Lopez-Beltran A, Cheng L, Mohanty SK. Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature. Histopathology. 2024 Nov; 85(5):748-759. PMID: 39075659.
      Citations:    
    9. Sanders JL, Iczkowski KA, Shah GV. Predicting the Diagnosis of Prostate Cancer with a Novel Blood-Based Biomarker: Comparison of Its Performance with Prostate-Specific Antigen. Cancers (Basel). 2024 Jul 23; 16(15). PMID: 39123347.
      Citations:    
    10. Karan D, Dubey S, Gunewardena S, Iczkowski KA, Singh M, Liu P, Poletti A, Choo YM, Chen HZ, Hamann MT. Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice. Mol Oncol. 2024 Aug; 18(8):1966-1979. PMID: 38605607.
      Citations:    
    11. Fernandez Gonzalez De La Vega C, Duenweg S, Jain P, Rubenstein SI, Bobholz S, Barrett MJ, LaViolette PS, Iczkowski KA. Morphologic features of prostate cancer-encased native vessels: An image analysis study. Pathol Res Pract. 2024 Apr; 256:155239. PMID: 38461692.
      Citations:    
    12. Maranto C, Sabharwal L, Udhane V, Pitzen SP, McCluskey B, Qi S, O'Connor C, Devi S, Johnson S, Jacobsohn K, Banerjee A, Iczkowski KA, Wang L, Dehm SM, Nevalainen MT. Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling. Sci Adv. 2024 Mar; 10(9):eadi2742. PMID: 38416822.
      Citations:    
    13. Nguyen NJ, Liu K, Lajkosz K, Iczkowski KA, van der Kwast TH, Downes MR. Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort. J Clin Pathol. 2024 Feb 20. PMID: 38378247.
      Citations:    
    14. Karan D, Wick J, Dubey S, Kumar-Sinha C, Siddiqui J, Kunju LP, Iczkowski KA, Chinnaiyan AM. Reply to "Contextualizing racial associations in prostate cancer to expose structural causes". Cancer. 2024 02 15; 130(4):647-648. PMID: 38079361.
      Citations:    
    15. Samaratunga H, Egevad L, Yaxley J, Perry-Keene J, Le Fevre I, Kench J, Matsika A, Bostwick D, Iczkowski K, Delahunt B. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients. Pathology. 2024 Feb; 56(1):33-38. PMID: 38071161.
      Citations:    
    16. Duenweg SR, Brehler M, Lowman AK, Bobholz SA, Kyereme F, Winiarz A, Nath B, Iczkowski KA, Jacobsohn KM, LaViolette PS. Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy. Lab Invest. 2023 12; 103(12):100269. PMID: 37898290.
      Citations:    
    17. Lopez-Beltran A, Raspollini MR, Hansel D, Comp?rat E, Williamson SR, Liedberg F, Iczkowski KA, Bubendorf L, van der Kwast TH, Cheng L. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer. Am J Surg Pathol. 2024 Jan 01; 48(1):e24-e31. PMID: 37737692.
      Citations:    
    18. Karan D, Wick J, Dubey S, Kumar-Sinha C, Siddiqui J, Kunju LP, Iczkowski KA, Chinnaiyan AM. Racial differences in serum chemokines in prostate cancer patients. Cancer. 2023 12 01; 129(23):3783-3789. PMID: 37698493.
      Citations:    
    19. Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM, Vincent-Sheldon S, LaViolette PS. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers (Basel). 2023 Sep 06; 15(18). PMID: 37760407.
      Citations:    
    20. Downes MR, Liu KN, Yu Y, Lajkosz K, Kroon LJ, Hollemans E, Fleshner N, Finelli A, van Leenders GJLH, Iczkowski KA, van der Kwast TH. Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. Clin Genitourin Cancer. 2024 02; 22(1):47-55. PMID: 37558528.
      Citations:    
    21. Duenweg SR, Bobholz SA, Lowman AK, Stebbins MA, Winiarz A, Nath B, Kyereme F, Iczkowski KA, LaViolette PS. Whole slide imaging (WSI) scanner differences influence optical and computed properties of digitized prostate cancer histology. J Pathol Inform. 2023; 14:100321. PMID: 37496560.
      Citations:    
    22. Li Z, Jiao X, Robertson AG, Di Sante G, Ashton AW, DiRocco A, Wang M, Zhao J, Addya S, Wang C, McCue PA, South AP, Cordon-Cardo C, Liu R, Patel K, Hamid R, Parmar J, DuHadaway JB, Jones SJM, Casimiro MC, Schultz N, Kossenkov A, Phoon LY, Chen H, Lan L, Sun Y, Iczkowski KA, Rui H, Pestell RG. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. Oncogene. 2023 Apr 24. PMID: 37095257.
      Citations:    
    23. Duenweg SR, Brehler M, Bobholz SA, Lowman AK, Winiarz A, Kyereme F, Nencka A, Iczkowski KA, LaViolette PS. Comparison of a machine and deep learning model for automated tumor annotation on digitized whole slide prostate cancer histology. PLoS One. 2023; 18(3):e0278084. PMID: 36928230.
      Citations:    
    24. Masud N, Aldahish A, Iczkowski KA, Kale A, Shah GV. Zinc finger protein-like 1 is a novel neuroendocrine biomarker for prostate cancer. Int J Oncol. 2023 Mar; 62(3). PMID: 36799165.
      Citations:    
    25. Egevad L, Delahunt B, Iczkowski KA, van der Kwast T, van Leenders GJLH, Leite KRM, Pan CC, Samaratunga H, Tsuzuki T, Mulliqi N, Ji X, Olsson H, Valkonen M, Ruusuvuori P, Eklund M, Kartasalo K. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria. Histopathology. 2023 May; 82(6):837-845. PMID: 36645163.
      Citations:    
    26. Pestell R, Li Z, Jiao X, Robertson A, Sante GD, Ashton A, DiRocco A, Wang M, Zhao J, Addya S, Wang C, McCue P, South A, Cordon-Cardo C, Liu R, Patel K, Hamid R, Parmar J, DuHadaway J, Jones S, Casimiro M, Schultz N, Kossenkov A, Phoon LY, Chen H, Lan L, Sun Y, Iczkowski K, Rui H. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. Res Sq. 2023 Jan 10. PMID: 36712010.
      Citations:    
    27. Berb?s MA, McClintock DS, Bychkov A, Van der Laak J, Pantanowitz L, Lennerz JK, Cheng JY, Delahunt B, Egevad L, Eloy C, Farris AB, Fraggetta F, Garc?a Del Moral R, Hartman DJ, Herrmann MD, Hollemans E, Iczkowski KA, Karsan A, Kriegsmann M, Salama ME, Sinard JH, Tuthill JM, Williams B, Casado-S?nchez C, S?nchez-Turri?n V, Luna A, Aneiros-Fern?ndez J, Shen J. Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade. EBioMedicine. 2023 Feb; 88:104427. PMID: 36603288.
      Citations:    
    28. Iczkowski KA. Malignant Mesothelioma of Tunica Vaginalis Testis: Update for 2022. Adv Anat Pathol. 2023 Jul 01; 30(4):259-261. PMID: 36129341.
      Citations:    
    29. Iczkowski KA, Molina M, Egevad L, Bostwick DG, van Leenders GJLH, La Rosa FG, van der Kwast T, Berney DM, Evans AJ, Wheeler TM, Leite KRM, Samaratunga H, Srigley J, Varma M, Tsuzuki T, Lucia MS, Crawford ED, Harris RG, Stricker P, Lawrentschuk N, Woo HH, Fleshner NE, Shore ND, Yaxley J, Bratt O, Wiklund P, Roberts M, Cheng L, Delahunt B. Low-grade prostate cancer should still be labelled cancer. BJU Int. 2022 12; 130(6):741-743. PMID: 36083240.
      Citations:    
    30. Iczkowski KA. Germ cell neoplasms of the testis: Update for 2022. Semin Diagn Pathol. 2023 Jan; 40(1):2-21. PMID: 35840444.
      Citations:    
    31. Taylor C, Puzyrenko A, Iczkowski KA. Trends in disagreement with outside genitourinary pathology diagnoses at an academic center. Pathol Res Pract. 2022 Aug; 236:153997. PMID: 35780705.
      Citations:    
    32. Puzyrenko A, Kumar SN, Pantazis CG, Iczkowski KA. Inverse co-expression of EZH2 and acetylated H3K27 in prostatic tissue. Ann Diagn Pathol. 2022 Aug; 59:151956. PMID: 35509134.
      Citations:    
    33. Puzyrenko A, Nomani L, Iczkowski K, Giorgadze T. Small cell carcinoma of the urinary bladder: Distinctive cytological characteristics and Cyto-histologic correlation. Ann Diagn Pathol. 2022 Aug; 59:151947. PMID: 35427925.
      Citations:    
    34. Singh CK, Denu RA, Nihal M, Shabbir M, Garvey DR, Huang W, Iczkowski KA, Ahmad N. PLK4 is upregulated in prostate cancer and its inhibition reduces centrosome amplification and causes senescence. Prostate. 2022 06; 82(9):957-969. PMID: 35333404.
      Citations:    
    35. Duenweg SR, Fang X, Bobholz SA, Lowman AK, Brehler M, Kyereme F, Iczkowski KA, Jacobsohn KM, Banerjee A, LaViolette PS. Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth. Tomography. 2022 03 02; 8(2):635-643. PMID: 35314630.
      Citations:    
    36. Williams AM, Jensen DM, Pan X, Liu P, Liu J, Huls S, Regner KR, Iczkowski KA, Wang F, Li J, Gallan AJ, Wang T, Baker MA, Liu Y, Lalehzari N, Liang M. Histologically resolved small RNA maps in primary focal segmental glomerulosclerosis indicate progressive changes within glomerular and tubulointerstitial regions. Kidney Int. 2022 04; 101(4):766-778. PMID: 35114200.
      Citations:    
    37. McGarry SD, Brehler M, Bukowy JD, Lowman AK, Bobholz SA, Duenweg SR, Banerjee A, Hurrell SL, Malyarenko D, Chenevert TL, Cao Y, Li Y, You D, Fedorov A, Bell LC, Quarles CC, Prah MA, Schmainda KM, Taouli B, LoCastro E, Mazaheri Y, Shukla-Dave A, Yankeelov TE, Hormuth DA, Madhuranthakam AJ, Hulsey K, Li K, Huang W, Huang W, Muzi M, Jacobs MA, Solaiyappan M, Hectors S, Antic T, Paner GP, Palangmonthip W, Jacobsohn K, Hohenwalter M, Duvnjak P, Griffin M, See W, Nevalainen MT, Iczkowski KA, LaViolette PS. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. J Magn Reson Imaging. 2021 Nov 12. PMID: 34767682.
      Citations:    
    38. Huang W, Randhawa R, Jain P, Iczkowski KA, Hu R, Hubbard S, Eickhoff J, Basu H, Roy R. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification. JAMA Netw Open. 2021 11 01; 4(11):e2132554. PMID: 34730818.
      Citations:    
    39. Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT. Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? Cancers (Basel). 2021 Oct 17; 13(20). PMID: 34680353.
      Citations:    
    40. Dernell C, Bhasin B, Iczkowski KA, Gallan AJ. Characterization of the Peritumoral Atrophic Band and Nonneoplastic Renal Parenchyma in Radical Nephrectomy Specimens. Am J Clin Pathol. 2021 Oct 13; 156(5):913-919. PMID: 34075420.
      Citations:    
    41. Chhabra G, Singh CK, Guzm?n-P?rez G, Ndiaye MA, Iczkowski KA, Ahmad N. Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice. J Invest Dermatol. 2022 04; 142(4):1145-1157.e7. PMID: 34597611.
      Citations:    
    42. van der Kwast TH, van Leenders GJ, Berney DM, Delahunt B, Evans AJ, Iczkowski KA, McKenney JK, Ro JY, Samaratunga H, Srigley JR, Tsuzuki T, Varma M, Wheeler TM, Egevad L. ISUP Consensus Definition of Cribriform Pattern Prostate Cancer. Am J Surg Pathol. 2021 08 01; 45(8):1118-1126. PMID: 33999555.
      Citations:    
    43. Terashvili M, Talluri B, Palangmonthip W, Iczkowski KA, Sanvanson P, Medda BK, Banerjee B, Cunningham CW, Sengupta JN. Peripheral antinociceptive effects of a bifunctional ? and d opioid receptor ligand in rat model of inflammatory bladder pain. Neuropharmacology. 2021 09 15; 196:108701. PMID: 34256047.
      Citations:    
    44. Iczkowski KA, van Leenders GJLH, van der Kwast TH. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2021 07 01; 45(7):1007. PMID: 33481387.
      Citations:    
    45. Rybicki BA, Sadasivan SM, Chen Y, Kravtsov O, Palangmonthip W, Arora K, Gupta NS, Williamson S, Bobbitt K, Chitale DA, Tang D, Rundle AG, Iczkowski KA. Growth and differentiation factor 15 and NF-?B expression in benign prostatic biopsies and risk of subsequent prostate cancer detection. Cancer Med. 2021 05; 10(9):3013-3025. PMID: 33784024.
      Citations:    
    46. Iczkowski KA, van Leenders GJLH, Tarima S, Wu R, Van der Kwast T, Berney DM, Evans AJ, Wheeler TM, Ro JY, Samaratunga H, Delahunt B, Srigley J, Varma M, Tsuzuki T, Egevad L. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts. Ann Diagn Pathol. 2021 Jun; 52:151733. PMID: 33780691.
      Citations:    
    47. Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. Ann Diagn Pathol. 2021 Jun; 52:151725. PMID: 33610958.
      Citations:    
    48. Bukowy JD, Foss H, McGarry SD, Lowman AK, Hurrell SL, Iczkowski KA, Banerjee A, Bobholz SA, Barrington A, Dayton A, Unteriner J, Jacobsohn K, See WA, Nevalainen MT, Nencka AS, Ethridge T, Jarrard DF, LaViolette PS. Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network. J Med Imaging (Bellingham). 2020 Sep; 7(5):057501. PMID: 33062803.
      Citations:    
    49. McGarry SD, Bukowy JD, Iczkowski KA, Lowman AK, Brehler M, Bobholz S, Nencka A, Barrington A, Jacobsohn K, Unteriner J, Duvnjak P, Griffin M, Hohenwalter M, Keuter T, Huang W, Antic T, Paner G, Palangmonthip W, Banerjee A, LaViolette PS. Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer. J Med Imaging (Bellingham). 2020 Sep; 7(5):054501. PMID: 32923510.
      Citations:    
    50. Iczkowski KA, van Leenders GJLH. Eight Endorsements of the International Society of Urological Pathology from the 2019 Consensus Conference on Grading of Prostatic Carcinoma. J Urol. 2021 01; 205(1):8-10. PMID: 32897768.
      Citations:    
    51. van Leenders GJLH, van der Kwast TH, Iczkowski KA. The 2019 International Society of Urological Pathology Consensus Conference on Prostate Cancer Grading. Eur Urol. 2021 06; 79(6):707-709. PMID: 32847702.
      Citations:    
    52. van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N, Paner GP, Samaratunga H, Schoots IG, Simko JP, Tsuzuki T, Varma M, Warren AY, Wheeler TM, Williamson SR, Iczkowski KA. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99. PMID: 32459716.
      Citations:    
    53. Garcia-Peterson LM, Ndiaye MA, Chhabra G, Singh CK, Guzm?n-P?rez G, Iczkowski KA, Ahmad N. CRISPR/Cas9-mediated Knockout of SIRT6 Imparts Remarkable Antiproliferative Response in Human Melanoma Cells in vitro and in vivo. Photochem Photobiol. 2020 11; 96(6):1314-1320. PMID: 32621766.
      Citations:    
    54. Gordetsky J, Spieker AJ, Pena MDCR, Kamanda S, Anderson MR, Cheville J, Boorjian S, Frank I, Granada CP, Comperat E, Hirsch MS, Iczkowski KA, Imblum B, Schwartz L, Giannico GA, Rais-Bahrami S. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV. Urology. 2020 10; 144:158-163. PMID: 32681917.
      Citations:    
    55. Egevad L, Swanberg D, Delahunt B, Str?m P, Kartasalo K, Olsson H, Berney DM, Bostwick DG, Evans AJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M, Eklund M. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading. Virchows Arch. 2020 Dec; 477(6):777-786. PMID: 32542445.
      Citations:    
    56. Palangmonthip W, Wu R, Tarima S, Bobholz SA, LaViolette PS, Gallan AJ, Iczkowski KA. Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer. Prostate. 2020 06; 80(9):687-697. PMID: 32271960.
      Citations:    
    57. Str?m P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, W?hlby C, Gr?nberg H, Rantalainen M, Egevad L, Eklund M. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020 02; 21(2):222-232. PMID: 31926806.
      Citations:    
    58. Ronen S, Czaja RC, Ronen N, Pantazis CG, Iczkowski KA. Small Cell Variant of Metastatic Melanoma: A Mimicker of Lymphoblastic Leukemia/Lymphoma. Dermatopathology (Basel). 2019 Oct-Dec; 6(4):231-236. PMID: 31966987.
      Citations:    
    59. Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT. Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. Mol Cancer Ther. 2019 Sep 23. PMID: 31548294.
      Citations:    
    60. Iczkowski KA, Czaja RC. Eosinophilic Kidney Tumors: Old and New. Arch Pathol Lab Med. 2019 12; 143(12):1455-1463. PMID: 31403331.
      Citations:    
    61. Kravtsov O, Hartley CP, Comp?rat EM, Iczkowski KA. KIF3B protein expression loss correlates with metastatic ability of prostate cancer. Am J Clin Exp Urol. 2019; 7(3):178-181. PMID: 31317057.
      Citations:    
    62. El-Meanawy A, Mueller C, Iczkowski KA. Improving sensitivity of amyloid detection by Congo red stain by using polarizing microscope and avoiding pitfalls. Diagn Pathol. 2019 Jun 14; 14(1):57. PMID: 31200733.
      Citations:    
    63. Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L. MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia. Mod Pathol. 2019 11; 32(11):1666-1674. PMID: 31189999.
      Citations:    
    64. Farooq A, Jorda M, Whittington E, Kryvenko ON, Braunhut BL, Pavan N, Proch?zkov? K, Zhang L, Rai S, Miller T, Liu J, Szabo A, Iczkowski KA. Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors. Am J Clin Pathol. 2019 04 02; 151(5):479-485. PMID: 30576407.
      Citations:    
    65. McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS. Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space. Tomography. 2019 Mar; 5(1):127-134. PMID: 30854450.
      Citations:    
    66. Iczkowski KA. Large-Gland Proliferations of the Prostate. Surg Pathol Clin. 2018 Dec; 11(4):687-712. PMID: 30447836.
      Citations:    
    67. Nir G, Hor S, Karimi D, Fazli L, Skinnider BF, Tavassoli P, Turbin D, Villamil CF, Wang G, Wilson RS, Iczkowski KA, Lucia MS, Black PC, Abolmaesumi P, Goldenberg SL, Salcudean SE. Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts. Med Image Anal. 2018 12; 50:167-180. PMID: 30340027.
      Citations:    
    68. Piotrowski JT, Schaefer MB, Charlson JA, Iczkowski KA, Johnson SC. Primary angiosarcoma of the testis with retroperitoneal metastasis. Urol Case Rep. 2018 Nov; 21:116-118. PMID: 30294549.
      Citations:    
    69. McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS. Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 Apr 24. PMID: 29908785.
      Citations:    
    70. Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, H?rnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M. Utility of Pathology Imagebase for standardisation of prostate cancer grading. Histopathology. 2018 Jul; 73(1):8-18. PMID: 29359484.
      Citations:    
    71. Bayat S, Azizi S, Daoud MI, Nir G, Imani F, Gerardo CD, Yan P, Tahmasebi A, Vignon F, Sojoudi S, Wilson S, Iczkowski KA, Lucia MS, Goldenberg L, Salcudean SE, Abolmaesumi P, Mousavi P. Investigation of Physical Phenomena Underlying Temporal-Enhanced Ultrasound as a New Diagnostic Imaging Technique: Theory and Simulations. IEEE Trans Ultrason Ferroelectr Freq Control. 2018 03; 65(3):400-410. PMID: 29505407.
      Citations:    
    72. Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. Clin Cancer Res. 2018 Feb 26. PMID: 29483142.
      Citations:    
    73. Mostafa ME, Abdelkader A, Kuroda N, P?rez-Montiel D, Banerjee A, Hes O, Iczkowski KA. Variation in nuclear size and PD-L2 positivity correlate with aggressive chromophobe renal cell carcinoma. Ann Diagn Pathol. 2018 Jun; 34:31-35. PMID: 29661724.
      Citations:    
    74. Iczkowski KA, Paner GP, Van der Kwast T. The New Realization About Cribriform Prostate Cancer. Adv Anat Pathol. 2018 Jan; 25(1):31-37. PMID: 28820750.
      Citations:    
    75. Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS. Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. J Med Imaging (Bellingham). 2018 01; 5(1):011004. PMID: 29098169.
      Citations:    
    76. Logunova V, Sokumbi O, Iczkowski KA. Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass. J Cutan Pathol. 2017 Oct; 44(10):874-877. PMID: 28675457.
      Citations:    
    77. Baker MA, Davis SJ, Liu P, Pan X, Williams AM, Iczkowski KA, Gallagher ST, Bishop K, Regner KR, Liu Y, Liang M. Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease. J Am Soc Nephrol. 2017 Oct; 28(10):2985-2992. PMID: 28663230.
      Citations:    
    78. Azizi S, Bayat S, Yan P, Tahmasebi A, Nir G, Kwak JT, Xu S, Wilson S, Iczkowski KA, Lucia MS, Goldenberg L, Salcudean SE, Pinto PA, Wood B, Abolmaesumi P, Mousavi P. Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations. Int J Comput Assist Radiol Surg. 2017 Aug; 12(8):1293-1305. PMID: 28634789.
      Citations:    
    79. Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D. Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. Clin Genitourin Cancer. 2017 10; 15(5):e897-e901. PMID: 28645484.
      Citations:    
    80. Ronen S, Abbott DW, Kravtsov O, Abdelkader A, Xu Y, Banerjee A, Iczkowski KA. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. Hum Pathol. 2017 07; 65:85-91. PMID: 28504208.
      Citations:    
    81. Iczkowski KA. Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5. Eur Urol. 2017 08; 72(2):e36. PMID: 28284740.
      Citations:    
    82. Iczkowski KA. Genomic Pathology and Cancer Biomarkers: Prostate Cancer. Crit Rev Oncog. 2017; 22(5-6):515-525. PMID: 29604929.
      Citations:    
    83. Singh CK, Malas KM, Tydrick C, Siddiqui IA, Iczkowski KA, Ahmad N. Analysis of Zinc-Exporters Expression in Prostate Cancer. Sci Rep. 2016 11 11; 6:36772. PMID: 27833104.
      Citations:    
    84. Hoang DT, Iczkowski KA, Kilari D, See W, Nevalainen MT. Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. Oncotarget. 2016 Oct 10. PMID: 27741508.
      Citations:    
    85. Iczkowski KA. Editorial Comment. J Urol. 2017 01; 197(1):82. PMID: 27717689.
      Citations:    
    86. Harding-Jackson N, Kryvenko ON, Whittington EE, Eastwood DC, Tjionas GA, Jorda M, Iczkowski KA. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8. J Urol. 2016 Oct; 196(4):1076-81. PMID: 27265220.
      Citations:    
    87. Aljameeli A, Thakkar A, Thomas S, Lakshmikanthan V, Iczkowski KA, Shah GV. Calcitonin Receptor-Zonula Occludens-1 Interaction Is Critical for Calcitonin-Stimulated Prostate Cancer Metastasis. PLoS One. 2016; 11(3):e0150090. PMID: 26934365.
      Citations:    
    88. Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES. Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients. Anticancer Res. 2016 Feb; 36(2):495-501. PMID: 26851002.
      Citations:    
    89. Khamis ZI, Iczkowski KA, Man YG, Bou-Dargham MJ, Sang QX. Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues. J Cancer. 2016; 7(1):80-7. PMID: 26722363.
      Citations:    
    90. Li H, Hes O, MacLennan GT, Eastwood DC, Iczkowski KA. Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor. Virchows Arch. 2015 May; 466(5):581-8. PMID: 25690138.
      Citations:    
    91. Lambert JR, Whitson RJ, Iczkowski KA, La Rosa FG, Smith ML, Wilson RS, Smith EE, Torkko KC, Gari HH, Lucia MS. Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate. Prostate. 2015 Feb 15; 75(3):255-65. PMID: 25327758.
      Citations:    
    92. Iczkowski KA, Egevad L, Ma J, Harding-Jackson N, Algaba F, Billis A, Camparo P, Cheng L, Clouston D, Comperat EM, Datta MW, Evans AG, Griffiths DF, Guo CC, Hailemariam S, Huang W, Humphrey PA, Jiang Z, Kahane H, Kristiansen G, La Rosa FG, Lopez-Beltran A, MacLennan GT, Magi-Galluzzi C, Merrimen J, Montironi R, Osunkoya AO, Picken MM, Rao N, Shah RB, Shanks JH, Shen SS, Tawfik OW, True LD, Van der Kwast T, Varma M, Wheeler TM, Zynger DL, Sahr N, Bostwick DG. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann Diagn Pathol. 2014 Dec; 18(6):333-42. PMID: 25263387.
      Citations:    
    93. Iczkowski KA. Prostate pointers and pitfalls: the 10 most prevalent problems in prostate biopsy interpretation. Ann Diagn Pathol. 2014 Oct; 18(5):301-11. PMID: 25128443.
      Citations:    
    94. Iczkowski KA. Paneth cell-like change in benign prostate can account for P504S (AMACR) reactivity. Int J Clin Exp Pathol. 2014; 7(6):3454-5. PMID: 25031776.
      Citations:    
    95. Dancik GM, Owens CR, Iczkowski KA, Theodorescu D. A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors. Stem Cells. 2014 Apr; 32(4):974-82. PMID: 24357085.
      Citations:    
    96. Villarreal-Calderon R, Lu?vano-Gonz?lez A, Arag?n-Flores M, Zhu H, Yuan Y, Xiang Q, Yan B, Stoll KA, Cross JV, Iczkowski KA, Mackinnon AC. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014 Jun; 18(3):129-35. PMID: 24656654.
      Citations:    
    97. Iczkowski KA, La Rosa FG. Gleason 6 cancer is still cancer. Oncology (Williston Park). 2014 Jan; 28(1):22, 24, 29. PMID: 24683715.
      Citations:    
    98. Iczkowski KA, Torkko KC, Wilson RS, Lucia MS, Bostwick DG. Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides. Hum Pathol. 2014 Jan; 45(1):54-8. PMID: 24157066.
      Citations:    
    99. Hohensee SE, La Rosa FG, Homer P, Suby-Long T, Wilson S, Lucia SM, Iczkowski KA. Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature. J Med Case Rep. 2013 Apr 29; 7:118. PMID: 23628229.
      Citations:    
    100. Raman SB, Nguyen MH, Cheng S, Badrane H, Iczkowski KA, Wegener M, Gaffen SL, Mitchell AP, Clancy CJ. A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis. Infect Immun. 2013 May; 81(5):1430-8. PMID: 23429534.
      Citations:    
    101. Iczkowski KA, Shanks JH, Burdge AH, Cheng L. Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report. Histopathology. 2013 Feb; 62(3):522-4. PMID: 23339367.
      Citations:    
    102. Iczkowski KA, Montironi R, Cao D, Magi-Galluzzi C, Lucia MS. Pathology update for urologists. Prostate Cancer. 2011; 2011:183761. PMID: 22096649.
      Citations:    
    103. Iczkowski KA, Pantazis CG. Papillary cystadenofibroma of epididymis: a case report. Int J Clin Exp Pathol. 2011 Aug 15; 4(6):629-31. PMID: 21904638.
      Citations:    
    104. Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, Lucia MS. Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome. Prostate Cancer. 2011; 2011:693853. PMID: 22110997.
      Citations:    
    105. Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, La Rosa FG, Cook S, Werahera PN, Lucia MS. Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome. Am J Clin Pathol. 2011 Jul; 136(1):98-107. PMID: 21685037.
      Citations:    
    106. Iczkowski KA, Lucia MS. Frequency of positive surgical margin at prostatectomy and its effect on patient outcome. Prostate Cancer. 2011; 2011:673021. PMID: 22110996.
      Citations:    
    107. Iczkowski KA, Lucia MS. Current perspectives on Gleason grading of prostate cancer. Curr Urol Rep. 2011 Jun; 12(3):216-22. PMID: 21424766.
      Citations:    
    108. Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate. 2011 Dec; 71(16):1746-51. PMID: 21480308.
      Citations:    
    109. Khamis ZI, Iczkowski KA, Sang QX. Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev. 2012 Sep; 32(5):1026-77. PMID: 22886631.
      Citations:    
    110. Vera PL, Iczkowski KA, Howard DJ, Jiang L, Meyer-Siegler KL. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice. Neurourol Urodyn. 2010 Nov; 29(8):1451-7. PMID: 20127836.
      Citations:    
    111. Iczkowski KA. Cell adhesion molecule CD44: its functional roles in prostate cancer. Am J Transl Res. 2010 Sep 12; 3(1):1-7. PMID: 21139802.
      Citations:    
    112. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010 Sep; 34(9):1367-76. PMID: 20717002.
      Citations:    
    113. Iczkowski KA. Chronic pelvic pain syndrome: a role for aberrant cytokine function. J Urol. 2010 Oct; 184(4):1253-4. PMID: 20723919.
      Citations:    
    114. Alisky JM, Tang Y, Habermehl GK, Iczkowski KA. Dutasteride prevents the growth response to testosterone in benign and androgen-sensitive malignant prostate cells. Int J Clin Exp Med. 2010 Jul 25; 3(3):245-7. PMID: 20827322.
      Citations:    
    115. Khamis ZI, Iczkowski KA, Sahab ZJ, Sang QX. Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues. J Cancer. 2010 Jun 15; 1:70-9. PMID: 20842227.
      Citations:    
    116. Qian J, Bostwick DG, Iczkowski KA, Betre K, Wilson MJ, LE C, Sinha AA. Characterization of prostate cancer in needle biopsy by cathepsin B, cell proliferation and DNA ploidy. Anticancer Res. 2010 Mar; 30(3):719-25. PMID: 20392989.
      Citations:    
    117. Yang K, Tang Y, Habermehl GK, Iczkowski KA. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer. 2010 Jan 14; 10:16. PMID: 20074368.
      Citations:    
    118. Yang K, Tang Y, Iczkowski KA. Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression. Am J Transl Res. 2010 Jan 01; 2(1):88-94. PMID: 20182585.
      Citations:    
    119. Shanks JH, Iczkowski KA. Spindle cell lesions of the bladder and urinary tract. Histopathology. 2009 Nov; 55(5):491-504. PMID: 19912355.
      Citations:    
    120. Nakamura K, Kasraeian A, Iczkowski KA, Chang M, Pendleton J, Anai S, Rosser CJ. Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol. 2009 Sep 10; 9:12. PMID: 19744317.
      Citations:    
    121. Lee WH, Hung MC, Iczkowski KA, Languino LR, Dubinett SM, Wang D. The launch of the american journal of translational research. Am J Transl Res. 2009; 1(1):i. PMID: 19966932.
      Citations:    
    122. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One. 2009 Sep 01; 4(9):e6872. PMID: 19721714.
      Citations:    
    123. Hao B, Clancy CJ, Cheng S, Raman SB, Iczkowski KA, Nguyen MH. Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulence. Eukaryot Cell. 2009 Apr; 8(4):627-39. PMID: 19252121.
      Citations:    
    124. Handorean AM, Yang K, Robbins EW, Flaig TW, Iczkowski KA. Silibinin suppresses CD44 expression in prostate cancer cells. Am J Transl Res. 2009 Jan 01; 1(1):80-6. PMID: 19966941.
      Citations:    
    125. Vera PL, Iczkowski KA, Wang X, Meyer-Siegler KL. Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS One. 2008; 3(12):e3898. PMID: 19066630.
      Citations:    
    126. Yang K, Handorean AM, Iczkowski KA. MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol. 2009; 2(4):361-9. PMID: 19158933.
      Citations:    
    127. Badrane H, Nguyen MH, Cheng S, Kumar V, Derendorf H, Iczkowski KA, Clancy CJ. The Candida albicans phosphatase Inp51p interacts with the EH domain protein Irs4p, regulates phosphatidylinositol-4,5-bisphosphate levels and influences hyphal formation, the cell integrity pathway and virulence. Microbiology (Reading). 2008 Nov; 154(Pt 11):3296-3308. PMID: 18957583.
      Citations:    
    128. Shanks JH, Iczkowski KA. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology. 2009 Jun; 54(7):885-900. PMID: 19178589.
      Citations:    
    129. Robbins EW, Travanty EA, Yang K, Iczkowski KA. MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells. BMC Cancer. 2008 Sep 15; 8:260. PMID: 18793421.
      Citations:    
    130. Iczkowski KA, Hossain D, Torkko KC, Qian J, Lucia MS, Wheeler TM, Rewcastle JC, Bostwick DG. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology. 2008 Jun; 71(6):1166-71. PMID: 18279927.
      Citations:    
    131. Iczkowski KA, Butler SL, Shanks JH, Hossain D, Schall A, Meiers I, Zhou M, Torkko KC, Kim SJ, MacLennan GT. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol. 2008 Feb; 39(2):275-81. PMID: 18045648.
      Citations:    
    132. Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, Gregersen PK, Leng L, Bucala R. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 2007 Dec; 8(8):646-52. PMID: 17728788.
      Citations:    
    133. Sahab ZJ, Iczkowski KA, Sang QX. Anion exchange fractionation of serum proteins versus albumin elimination. Anal Biochem. 2007 Sep 01; 368(1):24-32. PMID: 17618595.
      Citations:    
    134. Ostrov DA, Barnes CL, Smith LE, Binns S, Brusko TM, Brown AC, Quint PS, Litherland SA, Roopenian DC, Iczkowski KA. Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex. Tissue Antigens. 2007 Feb; 69(2):181-8. PMID: 17257322.
      Citations:    
    135. Goodison S, Nakamura K, Iczkowski KA, Anai S, Boehlein SK, Rosser CJ. Exogenous mycoplasmal p37 protein alters gene expression, growth and morphology of prostate cancer cells. Cytogenet Genome Res. 2007; 118(2-4):204-13. PMID: 18000372.
      Citations:    
    136. Moore CD, Iczkowski KA, Blue KM, Algood CB. Urothelial carcinoma recurrence in ileal orthotopic neobladder: urethrectomy and creation of ileal conduit. Urology. 2007 Jan; 69(1):184.e11-3. PMID: 17270649.
      Citations:    
    137. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol. 2006 Dec 15; 177(12):8730-9. PMID: 17142775.
      Citations:    
    138. Iczkowski KA, Montironi R. Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu. J Clin Pathol. 2006 Dec; 59(12):1327-30. PMID: 17142577.
      Citations:    
    139. Anai S, Goodison S, Shiverick K, Iczkowski K, Tanaka M, Rosser CJ. Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts. Hum Gene Ther. 2006 Oct; 17(10):975-84. PMID: 16984224.
      Citations:    
    140. De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, Cheng L, Datta M, Egevad L, Ertoy-Baydar D, Farre X, Farree X, Fine SW, Iczkowski KA, Ittmann M, Knudsen BS, Loda M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Pikarsky E, Pizov G, Rubin MA, Samaratunga H, Sebo T, Sesterhenn IA, Shah RB, Shah RB, Signoretti S, Simko J, Thomas G, Troncoso P, Tsuzuki TT, van Leenders GJ, Yang XJ, Zhou M, Figg WD, Hoque A, Hoque A, Lucia MS. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006 Oct; 30(10):1281-91. PMID: 17001160.
      Citations:    
    141. Cheng S, Clancy CJ, Zhang Z, Hao B, Wang W, Iczkowski KA, Pfaller MA, Nguyen MH. Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol. 2007 Feb; 9(2):492-501. PMID: 16987332.
      Citations:    
    142. Lee S, Desai KK, Iczkowski KA, Newcomer RG, Wu KJ, Zhao YG, Tan WW, Roycik MD, Sang QX. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res. 2006 Sep; 16(9):750-8. PMID: 16940965.
      Citations:    
    143. Clancy CJ, Nguyen MH, Alandoerffer R, Cheng S, Iczkowski K, Richardson M, Graybill JR. Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors. Microbiology (Reading). 2006 Aug; 152(Pt 8):2247-2255. PMID: 16849791.
      Citations:    
    144. Iczkowski KA, Butler SL. New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol. 2006 Aug; 28(4):181-7. PMID: 16927637.
      Citations:    
    145. Alisky JM, Chertkova EL, Iczkowski KA. Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. Med Hypotheses. 2006; 67(5):1090-4. PMID: 16843615.
      Citations:    
    146. Iczkowski KA, Omara-Opyene AL, Shah GV. The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression. Anticancer Res. 2006 Jul-Aug; 26(4B):2863-72. PMID: 16886606.
      Citations:    
    147. Iczkowski KA. Current prostate biopsy interpretation: criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains. Arch Pathol Lab Med. 2006 Jun; 130(6):835-43. PMID: 16740037.
      Citations:    
    148. Raman SB, Nguyen MH, Zhang Z, Cheng S, Jia HY, Weisner N, Iczkowski K, Clancy CJ. Candida albicans SET1 encodes a histone 3 lysine 4 methyltransferase that contributes to the pathogenesis of invasive candidiasis. Mol Microbiol. 2006 May; 60(3):697-709. PMID: 16629671.
      Citations:    
    149. Meyer-Siegler KL, Iczkowski KA, Vera PL. Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine. J Urol. 2006 Apr; 175(4):1523-8. PMID: 16516040.
      Citations:    
    150. Sabbisetti VS, Chirugupati S, Thomas S, Vaidya KS, Reardon D, Chiriva-Internati M, Iczkowski KA, Shah GV. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer. 2005 Nov 20; 117(4):551-60. PMID: 15929083.
      Citations:    
    151. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005 Sep; 29(9):1201-7. PMID: 16096410.
      Citations:    
    152. Meyer-Siegler KL, Iczkowski KA, Vera PL. Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer. 2005 Jul 06; 5:73. PMID: 16000172.
      Citations:    
    153. Vera PL, Iczkowski KA, Leng L, Bucala R, Meyer-Siegler KL. Macrophage migration inhibitory factor is released as a complex with alpha1-inhibitor-3 in the intraluminal fluid during bladder inflammation in the rat. J Urol. 2005 Jul; 174(1):338-43. PMID: 15947686.
      Citations:    
    154. Cooper GR, Staples ED, Iczkowski KA, Clancy CJ. Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc Pathol. 2005 May-Jun; 14(3):145-9. PMID: 15914299.
      Citations:    
    155. Iczkowski KA, Omara-Opyene AL, Kulkarni TR, Pansara M, Shah GV. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion. Anticancer Res. 2005 May-Jun; 25(3B):2075-83. PMID: 16158948.
      Citations:    
    156. Iczkowski KA, Gapin TB, Wajsman Z. Small lymphocytic lymphoma involving an enlarging complex renal cyst. Arch Pathol Lab Med. 2005 Jan; 129(1):111-2. PMID: 15628890.
      Citations:    
    157. Iczkowski KA, Qiu J, Qian J, Somerville MC, Rittmaster RS, Andriole GL, Bostwick DG. The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostate. Urology. 2005 Jan; 65(1):76-82. PMID: 15667867.
      Citations:    
    158. Kelly BJ, Mrstik ME, Ramos-Caro FA, Iczkowski KA. Papular elastolytic giant cell granuloma responding to hydroxychloroquine and quinacrine. Int J Dermatol. 2004 Dec; 43(12):964-6. PMID: 15569034.
      Citations:    
    159. Iczkowski KA, Omara-Opyene AL, Kl?sel R. Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cells. Mol Biotechnol. 2004 Oct; 28(2):97-103. PMID: 15477648.
      Citations:    
    160. Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004 Sep; 45(3):218-25. PMID: 15330799.
      Citations:    
    161. Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest. 2004 Jul; 84(7):894-907. PMID: 15107804.
      Citations:    
    162. Iczkowski KA, Katz G, Cascione CJ. Postoperative bladder washing cytology after transurethral resection. Can it predict the recurrence of urothelial carcinoma? Acta Cytol. 2004 May-Jun; 48(3):380-4. PMID: 15192954.
      Citations:    
    163. Iczkowski KA, Huang W, Mazzucchelli R, Pantazis CG, Stevens GR, Montironi R. Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT. Cancer. 2004 Jan 15; 100(2):294-9. PMID: 14716763.
      Citations:    
    164. Jiang Z, Iczkowski KA, Woda BA, Tretiakova M, Yang XJ. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004 Jan; 121(1):99-107. PMID: 14750247.
      Citations:    
    165. Iczkowski KA, Ferguson KL, Grier DD, Hossain D, Banerjee SS, McNeal JE, Bostwick DG. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases. Am J Surg Pathol. 2003 Dec; 27(12):1523-9. PMID: 14657711.
      Citations:    
    166. Iczkowski KA, Pantazis CG. Overexpression of NSAID-activated gene product in prostate cancer. Int J Surg Pathol. 2003 Jul; 11(3):159-66. PMID: 12894347.
      Citations:    
    167. Iczkowski KA, Bai S, Pantazis CG. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level. Anticancer Res. 2003 Jul-Aug; 23(4):3129-40. PMID: 12926045.
      Citations:    
    168. Bostwick DG, de la Roza G, Dundore P, Corica FA, Iczkowski KA. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate. 2003 May 15; 55(3):187-93. PMID: 12692784.
      Citations:    
    169. Iczkowski KA, Pantazis CG, Wollett FC. Lobular carcinoma of the breast metastatic to the epidural space: a potential mimic of giant cell bone tumor. Breast J. 2003 Jan-Feb; 9(1):44-6. PMID: 12558671.
      Citations:    
    170. Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma. Cancer. 2002 Dec 15; 95(12):2487-93. PMID: 12467061.
      Citations:    
    171. Iczkowski KA, Chen HM, Yang XJ, Beach RA. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002 Nov; 60(5):851-4. PMID: 12429314.
      Citations:    
    172. Iczkowski KA, Casella G, Seppala RJ, Jones GL, Mishler BA, Qian J, Bostwick DG. Needle core length in sextant biopsy influences prostate cancer detection rate. Urology. 2002 May; 59(5):698-703. PMID: 11992843.
      Citations:    
    173. Iczkowski KA, Katz G, Zander DS, Clapp WL. Malignant mesothelioma of tunica vaginalis testis: a fatal case with liver metastasis. J Urol. 2002 Feb; 167(2 Pt 1):645-6. PMID: 11792939.
      Citations:    
    174. Iczkowski KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R, Nascimento AG, Bostwick DG. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol. 2001 Oct; 14(10):1043-51. PMID: 11598176.
      Citations:    
    175. Nothnick WB, Fan F, Iczkowski KA, Ashwell R, Thomas P, Tawfik OW. CD44s expression is reduced in endometriotic lesions compared to eutopic endometrium in women with endometriosis. Int J Gynecol Pathol. 2001 Apr; 20(2):140-6. PMID: 11293159.
      Citations:    
    176. Iczkowski KA, Han AC, Edelson MI, Rosenblum NG. Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case report. J Reprod Med. 2000 Oct; 45(10):853-6. PMID: 11077639.
      Citations:    
    177. Iczkowski KA, Bostwick DG. Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey. Urology. 2000 Apr; 55(4):568-71. PMID: 10736505.
      Citations:    
    178. Cheville JC, Rao S, Iczkowski KA, Lohse CM, Pankratz VS. Cytokeratin expression in seminoma of the human testis. Am J Clin Pathol. 2000 Apr; 113(4):583-8. PMID: 10761461.
      Citations:    
    179. Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. Arch Pathol Lab Med. 2000 Jan; 124(1):98-107. PMID: 10629139.
      Citations:    
    180. Iczkowski KA, Cheng L, Qian J, Shanks J, Gadaleanu V, Bostwick DG, Ramnani DM. ASAP is a valid diagnosis. Atypical small acinar proliferation. Hum Pathol. 1999 Dec; 30(12):1403-4. PMID: 10667415.
      Citations:    
    181. Iczkowski KA, Bostwick DG. Prostate biopsy 1999: strategies and significance of pathological findings. Semin Urol Oncol. 1999 Nov; 17(4):177-86. PMID: 10632119.
      Citations:    
    182. Lu D, Tawfik O, Pantazis C, Hobart W, Chapman J, Iczkowski K. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression. Gynecol Oncol. 1999 Oct; 75(1):84-90. PMID: 10502431.
      Citations:    
    183. Iczkowski KA, Bostwick DG. Prostate biopsy interpretation. Current concepts, 1999. Urol Clin North Am. 1999 Aug; 26(3):435-52. PMID: 10494283.
      Citations:    
    184. Iczkowski KA, Shanks JH, Allsbrook WC, Lopez-Beltran A, Pantazis CG, Collins TR, Wetherington RW, Bostwick DG. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Histopathology. 1999 Aug; 35(2):150-6. PMID: 10460660.
      Citations:    
    185. Khair AA, Pacelli A, Iczkowski KA, Cheng L, Corica FA, Larson TR, Corica A, Bostwick DG. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? Urology. 1999 Jul; 54(1):67-72. PMID: 10414729.
      Citations:    
    186. Iczkowski KA, Sweat SD, Bostwick DG. Subepithelial pelvic hematoma of the kidney clinically mimicking cancer: report of six cases and review of the literature. Urology. 1999 Feb; 53(2):276-9. PMID: 9933039.
      Citations:    
    187. Corica FA, Iczkowski KA, Cheng L, Zincke H, Blute ML, Wendel A, Sebo TJ, Neumann R, Bostwick DG. Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. J Urol. 1999 Feb; 161(2):408-11. PMID: 9915413.
      Citations:    
    188. Iczkowski KA. Re: Editorial comment on clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1999 Jan; 161(1):231. PMID: 10037410.
      Citations:    
    189. Iczkowski KA, Cheng L, Crawford BG, Bostwick DG. Steam heat with an EDTA buffer and protease digestion optimizes immunohistochemical expression of basal cell-specific antikeratin 34betaE12 to discriminate cancer in prostatic epithelium. Mod Pathol. 1999 Jan; 12(1):1-4. PMID: 9950154.
      Citations:    
    190. Cheng L, Sebo TJ, Slezak J, Pisansky TM, Bergstralh EJ, Neumann RM, Iczkowski KA, Zincke H, Bostwick DG. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998 Nov 15; 83(10):2164-71. PMID: 9827721.
      Citations:    
    191. Iczkowski KA, Bostwick DG. The pathologist as optimist: cancer grade deflation in prostatic needle biopsies. Am J Surg Pathol. 1998 Oct; 22(10):1169-70. PMID: 9777978.
      Citations:    
    192. Bostwick DG, Iczkowski KA, Amin MB, Discigil G, Osborne B. Malignant lymphoma involving the prostate: report of 62 cases. Cancer. 1998 Aug 15; 83(4):732-8. PMID: 9708938.
      Citations:    
    193. Bostwick DG, Iczkowski KA. Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol. 1998 Aug; 16(3):118-23. PMID: 9741415.
      Citations:    
    194. Iczkowski KA, Bostwick DG, Roche PC, Cheville JC. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol. 1998 Aug; 11(8):774-9. PMID: 9720507.
      Citations:    
    195. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998 Jul; 17(1):89-97. PMID: 9667526.
      Citations:    
    196. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res. 1998 Jun 01; 58(11):2461-8. PMID: 9622090.
      Citations:    
    197. Iczkowski KA, Bostwick DG. Detection of early prostate cancer: serendipitous or systematic? JAMA. 1998 May 13; 279(18):1439; author reply 1441. PMID: 9600468.
      Citations:    
    198. Iczkowski KA, Bassler TJ, Schwob VS, Bassler IC, Kunnel BS, Orozco RE, Bostwick DG. Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology. 1998 May; 51(5):749-57; discussion 757-8. PMID: 9610588.
      Citations:    
    199. Iczkowski KA, Shanks JH, Bostwick DG. Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma. Histopathology. 1998 Apr; 32(4):322-7. PMID: 9602328.
      Citations:    
    200. Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages show promise as antimicrobial agents. J Infect. 1998 Jan; 36(1):5-15. PMID: 9515662.
      Citations:    
    201. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997 Dec; 21(12):1489-95. PMID: 9414193.
      Citations:    
    202. Bostwick DG, Iczkowski KA. Minimal criteria for the diagnosis of prostate cancer on needle biopsy. Ann Diagn Pathol. 1997 Dec; 1(2):104-29. PMID: 9869832.
      Citations:    
    203. St?rkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997 Sep 01; 80(5):987-9. PMID: 9307203.
      Citations:    
    204. Alisky JM, Iczkowski KA, Foti AA. Chronic fatigue syndrome. Am Fam Physician. 1991 Jul; 44(1):56, 61. PMID: 2058540.
      Citations:    
    205. Iczkowski KA, Hertelendy F. Participation of the cytoskeleton in avian granulosa cell steroidogenesis. Gen Comp Endocrinol. 1991 Jun; 82(3):355-63. PMID: 1652530.
      Citations:    
    206. Iczkowski KA, Sun EL, Gondos B. Morphometric study of the prepubertal rabbit testis: germ cell numbers and seminiferous tubule dimensions. Am J Anat. 1991 Mar; 190(3):266-72. PMID: 2048554.
      Citations:    
    207. Alisky JM, Iczkowski KA. Barriers to housing for deinstitutionalized psychiatric patients. Hosp Community Psychiatry. 1990 Jan; 41(1):93-5. PMID: 2295488.
      Citations:    
    Iczkowski's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (602)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _